Week of January 23, 2024 | Vol. 13, Issue 4

UPCOMING EVENTS

Events Hosted or Attended by Bourne Partners

Let's Meet!

Please reach out to Xan Smith to schedule a meeting with Bourne Partners in the following locations:

INDUSTRY M&A ACTIVITY

Recent Transactions, Trading Comps, Market Reports, M&A Pipeline

Recent Transactions

An Overview of Transactions Within Market Sub-segments

Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.

Trading Comps

A Breakdown of Relevant Trading Multiples

This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific subsectors.

Market Research

Insight Into Healthcare Related Industries

Bourne Brief: Navigating Tailwinds & Headwinds in Clinical Research Service

Bourne Partners - Nov 2023

M&A Pipeline

Representative Current Retained Sell-Side and Partnering Opportunities

Project Ester

Consumer Health | Strategic Partnering 

Partnering opportunity for launch and commercialization of novel OTC dry eye product



Project Nirvana

Pharma | Capital Raise

Investment opportunity in sterile injectable pharmaceutical manufacturer and compounder

Project Panther

Pharma Services | Sell-Side

Acquisition opportunity of OTC and personal care CDMO

Project Pearl

Pharma | Capital Raise

Investment opportunity in late clinical-stage biopharmaceutical company



Project Pine

Pharma Services | Capital Raise

Investment opportunity in sterile injectable CDMO

Project Trident

Pharma | Buy-Side

Seeking generic liquids or established brands across all formats sold through the hospital / institutional channel

Featured Headlines

A Sampling of Industry Headlines

Kindeva Drug Delivery Acquires Summit Biosciences, a Specialized Nasal Drug Development and Manufacturing Organization

Bourne Partners - Jan 18, 2024

Andelyn Biosciences and Armatus Bio Partner to Manufacture Suspension-Based AAV Gene Therapy for Rare Neurological Disease Charcot-Marie-Tooth Type 1A (CMT1A)

PR Newswire - Jan 15, 2024

LTS to support Micron Biomedical as strategic CDMO partner to scale up Micron´s Microarray Patch technology

LTS - Jan 15, 2024

Bora Pharmaceuticals to Acquire US Pharma Manufacturer Upsher-Smith for $210 Million in Transaction to Fuel Global Expansion

Bora Pharmaceuticals - Jan 16, 2024

NexPoint Launches Life Sciences III DST Offering for CDMO Manufacturing Property in Minnesota

NexPoint - Jan 16, 2024

KBI Biopharma, Inc. and Argonaut Manufacturing Services, Inc. Forge Strategic Alliance to Support Global Biopharmaceutical Companies with Integrated Drug Substance and Drug Product Solutions

Business Wire - Jan 16, 2024

Alcami Announces Acquisition of West-Coast Based Pacific Pharmaceutical Services

Alcami - Jan 17, 2024

Compass Pathways, Hackensack Meridian ink research deal for psilocybin treatment

Fierce Biotech - Jan 17, 2024

Prestige Biologics Signed 5-year CMO Service Agreement with Celltrion

Prestige Biologics - Jan 18, 2024

TANNER NEWS

Improving Lives by Increasing Access to Medicines Around the World

New year, same goal ➡️ improve lives. Join the Tanner journey. Let’s find ways to improve patient lives, together.

https://www.youtube.com/watch?v=9dAJo8WKQFk